This Healthcare Investor Added $43 Million to a Genomics Leader Growing Volume 34%

May 23, 2026
No Comments

Key PointsProsight bought 468,463 shares of GeneDx Holdings, estimated at $42.72 million based on average first-quarter 2026 prices.